TROW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TROW is not a good buy right now for an impatient investor. The setup is neutral-to-slightly bearish (MACD below zero, price sitting near the pivot with nearby resistance), proprietary signals show no edge today, and near-term event risk is elevated with earnings on 2026-02-04. If you must act immediately, the risk/reward is not compelling at 105–106 unless it cleanly reclaims ~107.6 (R1) with momentum; otherwise, the odds favor churn toward support (103.9) rather than a fast upside move.
Trend/Momentum: MACD histogram is -0.197 (below 0) and negatively contracting—bearish momentum is fading, but not reversed. RSI(6) 50.6 is neutral, implying no strong impulse either way. Moving averages are converging, consistent with consolidation rather than a clear trend.
Key levels: Pivot 105.719 is essentially current price (105.68 regular, ~104.39 post). Near resistance at R1 107.553 (then R2 108.686) could cap upside. Supports at S1 103.886 (then S2 102.753) are close—meaning downside tests are plausible if momentum slips.
Pattern-based short-term odds: Similar-pattern stats suggest modest upside next day/week (+1.05% / +2.96%) but weaker next month (-1.25%), aligning with a range-bound-to-soft bias.
Product/capability catalyst: Launch of Innovation Leaders ETF (TNXT) expands product shelf and can support longer-term flows/brand relevance.
Business narrative: Retirement market outlook emphasizes integrating private assets and AI-enabled services—supports a strategic growth story in retirement solutions.
Recent fundamentals: 2025/Q3 showed solid YoY growth in revenue, net income, and EPS, indicating operational resilience.
Upside catalyst window: Earnings on 2026-02-04 (pre-market) can trigger a quick re-rating if flows/margins beat expectations.
Near-term catalyst risk: Earnings on 2026-02-04 can create downside gaps if flows/outlook disappoint—important for an impatient buyer.
Options flow: Put-heavy volume (put/call volume 1.
signals near-term caution/hedging pressure.
Technical positioning: Price is near the pivot with nearby resistance (~107.6); without a momentum trigger, upside may be limited.
Macro/news tape: Broader market caution (jobs data, shutdown risk, big-tech earnings volatility) can weigh on asset managers via sentiment and flows.
Analyst skepticism: Multiple Underweight/Underperform stances and meaningful downside PT (e.g., BofA $
keep a lid on sentiment.
Latest reported quarter: 2025/Q3. Growth trends: Revenue $1.9465B (+6.56% YoY), Net Income $631.4M (+7.47% YoY), EPS $2.87 (+8.71% YoY). This is a steady, mid-to-high single digit growth profile, supportive of the business quality, but not enough by itself to justify chasing the stock immediately ahead of earnings without a technical/signal edge.
Recent trend (last ~2 months in the provided notes): Price targets were mixed but generally clustered around low-100s to mid-110s, with one notable bullish outlier (Morgan Stanley raised PT to $128, Equal Weight) and notable bearish pressure (BofA cut PT to $85, Underperform; Barclays stays Underweight around ~$102). Wall Street pros/cons view: Pros: Some expectation of constructive 2026 market conditions and recognition of efficiency/strategic initiatives; a few PT raises post-Q3 suggest earnings power is not broken. Cons: Persistent concern over net flows/outflows and Q4 softness; multiple firms maintain Underweight/Underperform/Hold-type ratings, implying limited conviction in near-term upside. Influential/political activity: No recent Congress trading data available; hedge fund and insider activity are reported as neutral (no significant recent trends).
